Featured Research

from universities, journals, and other organizations

First detailed data of risk of using Rasilez with certain blood pressure-lowering drugs

Date:
January 23, 2012
Source:
St. Michael's Hospital
Summary:
Researchers have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications.

Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications.

The pharmaceutical company Novartis terminated a large, international clinical trial of the drug last month after finding an increased incidence after 18-24 months of non-fatal strokes, renal complications, high levels of potassium in the blood and low blood pressure.

As a result, Health Canada said on Dec. 22 that it would review the safety of Rasilez, the brand name for aliskiren.

Even before Novartis halted its clinical trial, Dr. Ziv Harel and other researchers at St. Michael's were examining the interaction between Rasilez and angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blocker (ARB) drugs.

After reviewing 10 large randomized clinical trials on the combination of these drugs, they found that patients taking Rasilez as well as an ACE inhibitor or ARB, had about a 50 per cent greater risk of developing hyperkalemia -- high levels of potassium in the blood -- than those taking only an ACE inhibitor or ARB.

As well, patients taking a combination of Rasilez plus an ACE inhibitor or ARB had a 70 per cent greater risk of developing hyperkalemia than those taking Rasilez alone. Hyperkalemia can lead to an irregular heartbeat or increased risk of cardiac arrest.

Their analysis of the clinical trials was fast-tracked into publication this week in the British Medical Journal. It provided the first specific data of the risks of taking the drug combinations. Data was released from the halted Novartis trial, but a detailed analysis was not reported.

Previous research in 2008 found an increased risk of hyperkalemia and acute kidney failure in people taking a combination of ACE inhibitors and ARBs. So when Rasilez entered the market, clinicians were keen to replace one of those drugs in the combination. The number of prescriptions for Rasilez in Ontario rose from 56,602 in 2009 to 119,891 in 2010.

Dr. Harel, a nephrologist, said he was surprised to find no increased risk of kidney failure in patients taking Rasilez and an ACE inhibitor or ARB over those taking just one of the drugs. He said that might be because the short-term clinical trials they reviewed used a conservative definition of kidney failure or the patients were being monitored so closely that any sign of kidney damage would have been detected and treated quickly.

Dr. Harel said he believes that clinicians should offer alternatives to prescribing combinations of medications with a strong potential for life-threatening adverse events.


Story Source:

The above story is based on materials provided by St. Michael's Hospital. The original article was written by Leslie Shepherd. Note: Materials may be edited for content and length.


Journal Reference:

  1. Z. Harel, C. Gilbert, R. Wald, C. Bell, J. Perl, D. Juurlink, J. Beyene, P. S. Shah. The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis. BMJ, 2012; 344 (jan09 1): e42 DOI: 10.1136/bmj.e42

Cite This Page:

St. Michael's Hospital. "First detailed data of risk of using Rasilez with certain blood pressure-lowering drugs." ScienceDaily. ScienceDaily, 23 January 2012. <www.sciencedaily.com/releases/2012/01/120112112720.htm>.
St. Michael's Hospital. (2012, January 23). First detailed data of risk of using Rasilez with certain blood pressure-lowering drugs. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2012/01/120112112720.htm
St. Michael's Hospital. "First detailed data of risk of using Rasilez with certain blood pressure-lowering drugs." ScienceDaily. www.sciencedaily.com/releases/2012/01/120112112720.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How 'Yes Means Yes' Defines Sexual Assault

How 'Yes Means Yes' Defines Sexual Assault

Newsy (Sep. 29, 2014) Aimed at reducing sexual assaults on college campuses, California has adopted a new law changing the standard of consent for sexual activity. Video provided by Newsy
Powered by NewsLook.com
Scientists May Have Found An Early Sign Of Pancreatic Cancer

Scientists May Have Found An Early Sign Of Pancreatic Cancer

Newsy (Sep. 29, 2014) Researchers looked at 1,500 blood samples and determined people who developed pancreatic cancer had more branched chain amino acids. Video provided by Newsy
Powered by NewsLook.com
Colo. Doctors See Cluster of Enterovirus Cases

Colo. Doctors See Cluster of Enterovirus Cases

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com
Dr.'s Unsure of Cause of Fast-Spreading Virus

Dr.'s Unsure of Cause of Fast-Spreading Virus

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins